65551-77-1 Usage
Type of Compound
Pharmaceutical compound
Function
Antiplatelet agent and vasodilator
Mechanism of Action
Inhibits platelet aggregation and promotes vasodilation
Purpose
Prevents blood clots and improves blood flow
Usage
Often used in combination with other medications for heart valve replacements or at risk for thromboembolic events
Forms Available
Oral tablets and injectable solutions
Administration
Typically taken under the supervision of a healthcare professional
Tolerance
Generally well-tolerated
Possible Side Effects
Headache, dizziness, and gastrointestinal disturbances in some individuals
Check Digit Verification of cas no
The CAS Registry Mumber 65551-77-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,5,5 and 1 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 65551-77:
(7*6)+(6*5)+(5*5)+(4*5)+(3*1)+(2*7)+(1*7)=141
141 % 10 = 1
So 65551-77-1 is a valid CAS Registry Number.
65551-77-1Relevant academic research and scientific papers
Salts of 5-methylpyrazole-3-carboxylic acid with basically substituted adenine derivatives/Identification and lipolysis inhibitory activity
Credner,Tauscher,Jozic,Brenner
, p. 2096 - 2100 (2007/10/02)
5-Methylpyrazole-3-carboxylic acid forms salts with basically substituted adenine bases of type (4) or (5), which have significantly more lipolysis inhibitory activity than the free acid itself. The substance tested, 6-amino-9-[2-hydroxy-3-(N-methyl-N-2-hydroxyethyl)-aminopropyl]-purine-5-methylpyrazole-3-carboxylate (16), causes a significant reduction of serum FFA levels in fasted rats, even at the very low dosage of 0.150 mg/kg b.w., whereas the free 5-methyl-pyrazole-3-carboxylic-acid shows significant activity in this model only at doses of 2 mg/kg b.w. and above. The salt also shows similar activity on serum triglycerides. The effects on FFA, triglyceride and cholesterol levels, respectively, in fasted rats lasts for at least 8 h.
